Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03545698 · ClinicalTrials.gov registry record · NA

Enhancing and Scaling a High-Touch Home-based Primary Care Program

A NA study, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
56
Enrollment target

NCT03545698: Completed NA study, sponsored by Northwell Health.

NCT03545698 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03545698, a NA study, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target

Study Summary

The overall goal of the West Health Institute-Northwell PRP is to identify a clinical and economic model that can support scaling the Northwell House Calls program within a four year implementation period, while maintaining the same level of quality, patient/caregiver satisfaction, and "high touch" provider-patient communication that the program is known for. The Clinical Trial portion of this study refers to the secondary endpoint listed below.

Primary Outcome

The proportion of geriatric patients who agree to use telehealth for a care management visit in lieu of a phone call visit, out of those who are offered the service.

Interventions

  • OTHER Avizia Telehealth Platform

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2018-06-26
Est. Completion 2019-06-19
Phase NA
Northwell Health

370 total trials

What the finished NCT03545698 record still lists

NCT03545698 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Avizia Telehealth Platform is the first listed.

NCT03545698 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03545698 about?

NCT03545698 is a clinical study titled "Enhancing and Scaling a High-Touch Home-based Primary Care Program". The overall goal of the West Health Institute-Northwell PRP is to identify a clinical and economic model that can support scaling the Northwell House Calls program within a four year implementation period, while maintaining the same level of quality, patient/caregiver satisfaction, and "high touch" ...

What is the current status of trial NCT03545698?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2018-06-26. Estimated completion is 2019-06-19.

What interventions are being tested in trial NCT03545698?

The interventions under investigation include: Avizia Telehealth Platform (OTHER).

Who is sponsoring clinical trial NCT03545698?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03545698's enrollment target sits among peer trials

56 1262nd of 2000 higher than 737 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03545698, the US trial registry maintained by the National Library of Medicine. NCT03545698 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.